Use of a phosphodiesterase type 4 (PDE4) inhibitor particularly a pyrazolopyridine or a nucleic acid that inhibits the transcription of the PDE4B gene for the treatment of ocular degenerative disorders

摘要

Use of a phosphodiesterase type 4 (PDE4) inhibitor in pharmaceutical compositions for the treatment of ocular degenerative disorders. ACTIVITY : Ophthalmological. MECHANISM OF ACTION : Phosphodiesterase type 4B inhibitors; Antisense gene therapy.